Kava Balance
Natural health product licensed in Canada
- Licence holder
- 2158894 Ontario Inc.
- NPN or DIN-HM
- 80044220
- Status
- Active licence
- Licence date
- 20 August 2013
- Revision date
- 24 September 2019
- Form
- Capsule, dur
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Hypromellose, Maltodextrine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Helps relieve nervousness. Calmative. Sedative. Sleep aid / Helps to promote sleep.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult your health care practitioner prior to use if using conventional sedative-hypnotics (or natural health products with similar effects) anxiolytics, MAO inhibitors, and other psychopharmacologic agents, levodopa (or other drugs for Parkinson's disease), or anti-platelet agents. Consumption with alcohol, other medications or anti-convulsants is not recommended. Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner if sleeplessness persists continuously for more than 3 weeks. Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you suffer from epilepsy. Discontinue use and consult a health care practitioner if you develop symptoms that may signal liver problems (e.g. unexplained fatigue, abdominal pain, fever, vomiting, dark urine, yellow eyes or skin).
Source
Official Health Canada record, licence 80044220
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2019. Photograph the packaging to check whether it has changed. Photograph the packaging